JP3086837B2 - Method for producing 3-aminopyrrolidines - Google Patents
Method for producing 3-aminopyrrolidinesInfo
- Publication number
- JP3086837B2 JP3086837B2 JP03160877A JP16087791A JP3086837B2 JP 3086837 B2 JP3086837 B2 JP 3086837B2 JP 03160877 A JP03160877 A JP 03160877A JP 16087791 A JP16087791 A JP 16087791A JP 3086837 B2 JP3086837 B2 JP 3086837B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- general formula
- represented
- formula
- aminopyrrolidines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- NGXSWUFDCSEIOO-UHFFFAOYSA-N pyrrolidin-3-amine Chemical class NC1CCNC1 NGXSWUFDCSEIOO-UHFFFAOYSA-N 0.000 title claims description 14
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 238000000034 method Methods 0.000 claims description 20
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- 125000003342 alkenyl group Chemical group 0.000 claims description 11
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 10
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical group [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 9
- 125000002252 acyl group Chemical group 0.000 claims description 9
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims description 9
- 125000001424 substituent group Chemical group 0.000 claims description 9
- 125000003545 alkoxy group Chemical group 0.000 claims description 8
- 125000003118 aryl group Chemical group 0.000 claims description 8
- 229910052751 metal Inorganic materials 0.000 claims description 8
- 239000002184 metal Substances 0.000 claims description 8
- QQSBGBBBMKKBIC-UHFFFAOYSA-N pyrrolidin-3-imine Chemical compound N=C1CCNC1 QQSBGBBBMKKBIC-UHFFFAOYSA-N 0.000 claims description 8
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 6
- 125000004423 acyloxy group Chemical group 0.000 claims description 5
- 125000004104 aryloxy group Chemical group 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 125000004434 sulfur atom Chemical group 0.000 claims description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 3
- 229910017052 cobalt Chemical group 0.000 claims description 3
- 239000010941 cobalt Chemical group 0.000 claims description 3
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical group [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 3
- 229910052759 nickel Inorganic materials 0.000 claims description 3
- -1 etc.) Chemical group 0.000 description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000000243 solution Substances 0.000 description 12
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 11
- 239000012279 sodium borohydride Substances 0.000 description 11
- 229910000033 sodium borohydride Inorganic materials 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 238000001914 filtration Methods 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- QYXRREXPAUULFK-UHFFFAOYSA-N n-(1-benzyl-2-methylpyrrolidin-3-ylidene)hydroxylamine Chemical compound C1CC(=NO)C(C)N1CC1=CC=CC=C1 QYXRREXPAUULFK-UHFFFAOYSA-N 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 230000002194 synthesizing effect Effects 0.000 description 4
- SFEGZLNDKUGHQJ-UHFFFAOYSA-N 1-benzyl-2-methylpyrrolidin-3-amine Chemical compound CC1C(N)CCN1CC1=CC=CC=C1 SFEGZLNDKUGHQJ-UHFFFAOYSA-N 0.000 description 3
- UNHOPMIDKWXFMF-UHFFFAOYSA-N 1-methylpyrrolidin-3-amine Chemical compound CN1CCC(N)C1 UNHOPMIDKWXFMF-UHFFFAOYSA-N 0.000 description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 3
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 3
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000007868 Raney catalyst Substances 0.000 description 3
- 229910000564 Raney nickel Inorganic materials 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 3
- QDWJUBJKEHXSMT-UHFFFAOYSA-N boranylidynenickel Chemical compound [Ni]#B QDWJUBJKEHXSMT-UHFFFAOYSA-N 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 3
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 3
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 3
- SBMSLRMNBSMKQC-UHFFFAOYSA-N pyrrolidin-1-amine Chemical compound NN1CCCC1 SBMSLRMNBSMKQC-UHFFFAOYSA-N 0.000 description 3
- SIMYCJOGGRXQIY-UHFFFAOYSA-N 3-chloropyrrolidine Chemical compound ClC1CCNC1 SIMYCJOGGRXQIY-UHFFFAOYSA-N 0.000 description 2
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 2
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- HGAWACRPWVRCFI-UHFFFAOYSA-N n-pyrrolidin-3-ylidenehydroxylamine Chemical compound ON=C1CCNC1 HGAWACRPWVRCFI-UHFFFAOYSA-N 0.000 description 2
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- QIVUCLWGARAQIO-OLIXTKCUSA-N (3s)-n-[(3s,5s,6r)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2-oxospiro[1h-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide Chemical compound C1([C@H]2[C@H](N(C(=O)[C@@H](NC(=O)C=3C=C4C[C@]5(CC4=NC=3)C3=CC=CN=C3NC5=O)C2)CC(F)(F)F)C)=C(F)C=CC(F)=C1F QIVUCLWGARAQIO-OLIXTKCUSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 1
- KQGNDKNHORROII-UHFFFAOYSA-N 1-benzyl-2-methylpyrrolidin-3-one Chemical compound C1CC(=O)C(C)N1CC1=CC=CC=C1 KQGNDKNHORROII-UHFFFAOYSA-N 0.000 description 1
- GEZSNOKHPRRTIC-UHFFFAOYSA-N 1-benzyl-5-methylpyrrolidin-3-amine Chemical compound CC1CC(N)CN1CC1=CC=CC=C1 GEZSNOKHPRRTIC-UHFFFAOYSA-N 0.000 description 1
- HBVNLKQGRZPGRP-UHFFFAOYSA-N 1-benzylpyrrolidin-3-amine Chemical compound C1C(N)CCN1CC1=CC=CC=C1 HBVNLKQGRZPGRP-UHFFFAOYSA-N 0.000 description 1
- TWDMWOCACJHZNX-UHFFFAOYSA-N 2-methyl-1-propylpyrrolidin-3-amine Chemical compound CCCN1CCC(N)C1C TWDMWOCACJHZNX-UHFFFAOYSA-N 0.000 description 1
- OBFFLNVYKSXULV-UHFFFAOYSA-N 2-methyloxolan-3-amine Chemical compound CC1OCCC1N OBFFLNVYKSXULV-UHFFFAOYSA-N 0.000 description 1
- KCFCHQFZOXTLFP-UHFFFAOYSA-N 2-methylpyrrolidin-3-amine Chemical compound CC1NCCC1N KCFCHQFZOXTLFP-UHFFFAOYSA-N 0.000 description 1
- HFGHRUCCKVYFKL-UHFFFAOYSA-N 4-ethoxy-2-piperazin-1-yl-7-pyridin-4-yl-5h-pyrimido[5,4-b]indole Chemical compound C1=C2NC=3C(OCC)=NC(N4CCNCC4)=NC=3C2=CC=C1C1=CC=NC=C1 HFGHRUCCKVYFKL-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical class OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 1
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000561 anti-psychotic effect Effects 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- ZCRZCMUDOWDGOB-UHFFFAOYSA-N ethanesulfonimidic acid Chemical group CCS(N)(=O)=O ZCRZCMUDOWDGOB-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 150000004687 hexahydrates Chemical class 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 125000006518 morpholino carbonyl group Chemical group [H]C1([H])OC([H])([H])C([H])([H])N(C(*)=O)C1([H])[H] 0.000 description 1
- OMJMGFBLFFHEBE-UHFFFAOYSA-N n-(1-benzyl-5-methylpyrrolidin-3-ylidene)hydroxylamine Chemical compound CC1CC(=NO)CN1CC1=CC=CC=C1 OMJMGFBLFFHEBE-UHFFFAOYSA-N 0.000 description 1
- HSZHOSLGNAZGRD-UHFFFAOYSA-N n-(2-methyloxolan-3-ylidene)hydroxylamine Chemical compound CC1OCCC1=NO HSZHOSLGNAZGRD-UHFFFAOYSA-N 0.000 description 1
- AYOOGWWGECJQPI-NSHDSACASA-N n-[(1s)-1-(5-fluoropyrimidin-2-yl)ethyl]-3-(3-propan-2-yloxy-1h-pyrazol-5-yl)imidazo[4,5-b]pyridin-5-amine Chemical compound N1C(OC(C)C)=CC(N2C3=NC(N[C@@H](C)C=4N=CC(F)=CN=4)=CC=C3N=C2)=N1 AYOOGWWGECJQPI-NSHDSACASA-N 0.000 description 1
- VOVZXURTCKPRDQ-CQSZACIVSA-N n-[4-[chloro(difluoro)methoxy]phenyl]-6-[(3r)-3-hydroxypyrrolidin-1-yl]-5-(1h-pyrazol-5-yl)pyridine-3-carboxamide Chemical compound C1[C@H](O)CCN1C1=NC=C(C(=O)NC=2C=CC(OC(F)(F)Cl)=CC=2)C=C1C1=CC=NN1 VOVZXURTCKPRDQ-CQSZACIVSA-N 0.000 description 1
- LAIZPRYFQUWUBN-UHFFFAOYSA-L nickel chloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].[Cl-].[Ni+2] LAIZPRYFQUWUBN-UHFFFAOYSA-L 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- XULSCZPZVQIMFM-IPZQJPLYSA-N odevixibat Chemical compound C12=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C=3C=CC(O)=CC=3)C=C2S(=O)(=O)NC(CCCC)(CCCC)CN1C1=CC=CC=C1 XULSCZPZVQIMFM-IPZQJPLYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000000565 sulfonamide group Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- LMYRWZFENFIFIT-UHFFFAOYSA-N toluene-4-sulfonamide Chemical group CC1=CC=C(S(N)(=O)=O)C=C1 LMYRWZFENFIFIT-UHFFFAOYSA-N 0.000 description 1
- KMIOJWCYOHBUJS-HAKPAVFJSA-N vorolanib Chemical compound C1N(C(=O)N(C)C)CC[C@@H]1NC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C KMIOJWCYOHBUJS-HAKPAVFJSA-N 0.000 description 1
Landscapes
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Pyrrole Compounds (AREA)
Description
【0001】[0001]
【産業上の技術分野】本発明は一般式(II)The present invention relates to a compound represented by the general formula (II):
【0002】[0002]
【化4】 〔式中、ZはN−R1 、酸素原子又は硫黄原子を表わ
し、R1 は水素原子、置換もしくは未置換のアルキル
基、アルケニル基、アラルキル基、アリール基、アルコ
キシカルボニル基、アリールオキシカルボニル基、又は
アシル基を表し、R2 は水素原子、ハロゲン原子、置換
もしくは未置換のアルキル基、アルケニル基、アラルキ
ル基、アリール基、ヒドロキシル基、アルコキシ基、ア
リールオキシ基、アシルオキシ基、カルボキシル基、ア
ルコキシカルボニル基、アリールオキシカルボニル基、
又はアシル基を表わす。〕で表わされる3−アミノピロ
リジン類の製造方法に関する。Embedded image [In the formula, Z represents NR 1 , an oxygen atom or a sulfur atom, and R 1 represents a hydrogen atom, a substituted or unsubstituted alkyl group, an alkenyl group, an aralkyl group, an aryl group, an alkoxycarbonyl group, an aryloxycarbonyl group. Or an acyl group, and R 2 represents a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group, an alkenyl group, an aralkyl group, an aryl group, a hydroxyl group, an alkoxy group, an aryloxy group, an acyloxy group, a carboxyl group, an alkoxy group. Carbonyl group, aryloxycarbonyl group,
Or an acyl group. And a process for producing 3-aminopyrrolidines represented by the formula:
【0003】[0003]
【産業上の利用分野】本発明の前記一般式(II)で表
わされる3−アミノピロリジン類は医薬、農薬等の原料
として有用な化合物である。例えば、ヨーロッパ特許第
132,845号に記載の如く、1−ベンジル−3−ア
ミノピロリジンは1,8−ナフチリジン抗菌剤の原料と
して用いられる。又、特開昭57−2266号に記載の
如く、1−ベンジル−2−メチル−3−アミノピロリジ
ンの2,3−cis異性体は抗精神病薬の原料として用
いられる。BACKGROUND OF THE INVENTION The 3-aminopyrrolidines represented by the general formula (II) of the present invention are useful compounds as raw materials for medicines, agricultural chemicals and the like. For example, as described in EP 132,845, 1-benzyl-3-aminopyrrolidine is used as a raw material for 1,8-naphthyridine antibacterial agents. As described in JP-A-57-2266, the 2,3-cis isomer of 1-benzyl-2-methyl-3-aminopyrrolidine is used as a raw material for an antipsychotic.
【0004】[0004]
【従来の技術】従来から、3−アミノピロリジン類を合
成する方法については多くの研究があり、例えば、「ジ
ャーナル・オブ・メディシナル・ケミストリー(Journa
l of Medicinal Chemistry)」11巻(5号),193
4頁(1968)や英国特許第1,392,194号に
は、例えば3−クロロピロリジンを原料として、対応す
るアミノピロリジンを得る方法が記載されている。しか
し原料の3−クロロピロリジンの合成が難しく、又、中
間体としてフタルイミドを経なければならないなど工業
的に有利な方法とは言えない。又、一般的には「ジャー
ナル・オブ・メディシナル・ケミストリー(Journal of
Medicinal Chemistry)」24巻(10号),1244頁
(1981)や特開昭55−22699号に示されてい
る如く、ラネーニッケルを触媒として、対応する3−ヒ
ドロキシイミノピロリジンを還元する方法が知られてい
る。しかしこの方法では触媒のラネーニッケルを大量に
使用するために発火の危険が大きいことや、収率が低い
ことから工業的に有利な方法とは言えない。又、さらに
例えば、1−ベンジル−2−メチル−3−ヒドロキシイ
ミノピロリジンからは対応する3−アミノピロリジンの
2,3−cis異性体とtrans異性体が等量混合物
としてのみ得られ、試みたあらゆる条件下でcis異性
体の選択性は認知できなかった。2. Description of the Related Art There have been many studies on a method for synthesizing 3-aminopyrrolidines, for example, see "Journa of Medicinal Chemistry".
l of Medicinal Chemistry) ", 11 (5), 193
Page 4 (1968) and British Patent No. 1,392,194 describe a method for obtaining the corresponding aminopyrrolidine using, for example, 3-chloropyrrolidine as a raw material. However, it is difficult to synthesize 3-chloropyrrolidine as a raw material, and phthalimide must be used as an intermediate, which is not an industrially advantageous method. Also, generally, `` Journal of Medicinal Chemistry
Medicinal Chemistry), Vol. 24 (No. 10), p. 1244 (1981) and JP-A No. 55-22699, a method for reducing the corresponding 3-hydroxyiminopyrrolidine using Raney nickel as a catalyst is known. ing. However, this method is not industrially advantageous because it uses a large amount of Raney nickel as a catalyst and thus has a high risk of ignition and a low yield. Further, for example, from 1-benzyl-2-methyl-3-hydroxyiminopyrrolidine, the corresponding 2,3-cis isomer and trans isomer of 3-aminopyrrolidine are obtained only as an equal mixture, and Under the conditions, the selectivity of the cis isomer was not noticeable.
【0005】3位のアミノ基とそれぞれ2位、4位又は
5位の置換基がcis配置である異性体を得るには、対
応する3−ヒドロキシイミノピロリジンから、通常の水
素還元反応で得られるcis体とtrans体の混合物
を適当な方法、例えばカルボン酸塩にして分割する以外
に適当な方法が見当たらない。一方限られた置換基の化
合物については立体選択的に合成する方法が知られてい
る。すなわち、「ジャーナル・オブ・メディシナル・ケ
ミストリー(Journal of Medicinal Chemistry)」24巻
(10号),1244頁(1981)に、1−ベンジル
−2−メチル−3−アミノピロリジンの2,3−cis
体とtrans体の混合物からフマル酸の塩としてci
s体を分割する方法が記載されているが、収率が低く、
実用上問題点が多い。このような分画方法を適用する場
合には、混合物中のcis比率の大きさは分画収率に増
幅して影響を及ぼすので、高収率で目的物を得るにはc
is比率を可能な限り高めておくことが重要である。立
体選択的に合成する方法も、例えば「ジャーナル・オブ
・メディシナル・ケミストリー(Journal of Medicinal
Chemistry)」33巻(5号),1344頁(1990)
に、3,4−cis体を選択的に得る方法が記されてい
るが、下記の化学式で示すように反応工程が著しく長く
煩雑であり、前記一般式(II)の置換基R2 の種類が
限られ、汎用性に乏しい。さらに中間体にアジド基を有
する化合物を経るなど、安全上からも工業的合成法とし
て応用するには困難が伴うと考えられる。In order to obtain an isomer in which the amino group at the 3-position and the substituent at the 2-, 4- or 5-position respectively have the cis configuration, the isomer can be obtained from the corresponding 3-hydroxyiminopyrrolidine by a usual hydrogen reduction reaction. No suitable method has been found other than resolving the mixture of the cis form and the trans form into a carboxylate, for example. On the other hand, a method of stereoselectively synthesizing a compound having a limited substituent is known. That is, "Journal of Medicinal Chemistry", Vol. 24 (No. 10), p. 1244 (1981) describes 2,3-cis of 1-benzyl-2-methyl-3-aminopyrrolidine.
As a fumaric acid salt from a mixture of
Although a method for resolving the s-isomer is described, the yield is low,
There are many practical problems. When such a fractionation method is applied, the size of the cis ratio in the mixture amplifies and affects the fractionation yield.
It is important to keep the is ratio as high as possible. The method of stereoselectively synthesizing is also described in, for example, `` Journal of Medicinal Chemistry (Journal of Medicinal Chemistry)
Chemistry) 33 (5), 1344 (1990)
Describes a method for selectively obtaining a 3,4-cis form, but the reaction step is extremely long and complicated as shown by the following chemical formula, and the type of the substituent R 2 in the general formula (II) is described. Is limited and lacks versatility. Further, it is considered that application of the compound as an industrial synthetic method is difficult from the viewpoint of safety, for example, through a compound having an azide group as an intermediate.
【0006】[0006]
【化5】 Embedded image
【0007】[0007]
【発明が解決しようとする課題】上記の如く、現在知ら
れている3−アミノピロリジン類の製造方法には、多く
の問題が有り工業的方法として満足出来るものではな
い。As described above, the currently known methods for producing 3-aminopyrrolidines have many problems and are not satisfactory as industrial methods.
【0008】かくして本発明の目的は、従来の方法と比
較して、簡便かつ温和な条件で高品質の3−アミノピロ
リジン類を高収率で製造する経済的な方法を提供するこ
とにある。Thus, an object of the present invention is to provide an economical method for producing high-quality 3-aminopyrrolidines in a high yield under simple and mild conditions as compared with the conventional methods.
【0009】さらにはピロリジン環の3位のアミノ基と
それぞれ2位、4位又は5位の置換基がcis配置であ
る異性体を、高選択的に合成する方法を提供することに
ある。It is still another object of the present invention to provide a method for highly selectively synthesizing an isomer in which the amino group at the 3-position of the pyrrolidine ring and the substituent at the 2-, 4- or 5-position are in a cis configuration.
【0010】[0010]
【課題を解決するための手段】本発明者らは、上記課題
を解決するべく、3−アミノピロリジン類の合成反応に
ついて鋭意研究を続けた結果、還元触媒として金属ボラ
イド、還元剤として例えばソジウムボロハイドライドを
使用することにより、常圧下、温和な条件で高品質の3
−アミノピロリジン類が高収率で得られることを見出
し、本発明を完成するに至った。Means for Solving the Problems In order to solve the above-mentioned problems, the present inventors have made intensive studies on the synthesis reaction of 3-aminopyrrolidines. As a result, metal boride was used as a reducing catalyst, and sodium was used as a reducing agent, for example. By using borohydride, high quality 3 under normal pressure and mild conditions
The present inventors have found that -aminopyrrolidines can be obtained in high yield, and have completed the present invention.
【0011】即ち、本発明は前記一般式(I)で表わさ
れる3−イミノピロリジン誘導体から前記一般式(I
I)で表わされる3−アミノピロリジン誘導体を製造す
るにあたり、前記一般式(III)で表わされる金属ボ
ライドの存在下、還元することを特徴とする3−アミノ
ピロリジン類の製造方法に関するものである。That is, the present invention provides a method for preparing a compound of the formula (I) from a 3-iminopyrrolidine derivative represented by the formula (I).
The present invention relates to a method for producing 3-aminopyrrolidines, which comprises reducing the 3-aminopyrrolidine derivative represented by I) in the presence of the metal boride represented by the general formula (III).
【0012】下記一般式(I)The following general formula (I)
【0013】[0013]
【化6】 で表わされる化合物において、ZはN−R1 、酸素原子
又は硫黄原子を表わし、R1 は例えば、水素原子、未置
換アルキル基(例えば、メチル基、エチル基、プロピル
基、イソプロピル基、オクチル基、デシル基、シクロヘ
キシル基など)、置換基を有するアルキル基〔置換基と
しては、例えば、カルボキシル基、ハロゲン原子(例え
ば、フッ素原子、塩素原子など)、ヒドロキシル基、ア
ルコキシカルボニル基(例えば、メトキシカルボニル
基、エトキシカルボニル基、ベンジルオキシカルボニル
基など)、アリールオキシカルボニル基(例えばフェノ
キシカルボニル基など)、アルコキシ基(例えば、メト
キシ基、エトキシ基、ベンジルオキシ基、フェネチルオ
キシ基など)、単環式のアリールオキシ基(例えば、フ
ェノキシ基、p−トリルオキシ基など)、アシルオキシ
基(例えば、アセチルオキシ基、プロピオニルオキシ
基、カプリルオキシ基など)、カルバモイル基(例え
ば、カルバモイル基、N,N−ジメチルカルバモイル
基、モルホリノカルボニル基、ピペリジノカルボニル基
など)、スルファモイル基(例えば、スルファモイル
基、N,N−ジメチルスルファモイル基、モルホリノス
ルファモイル基など)、アシルアミノ基(例えば、アセ
チルアミノ基、プロピオニルアミノ基、ベンゾイルアミ
ノ基、メシルアミノ基など)、スルホンアミド基(例え
ば、エチルスルホンアミド基、p−トルエンスルホンア
ミド基など)を挙げることが出来る〕、アルケニル基
(例えば、アリル基、3−ブテニル基など)、アラルキ
ル基(例えば、ベンジル基、4−クロロベンジル基、4
−メチルベンジル基、1−ナフチルメチル基など)、ア
リール基(例えば、フェニル基、4−メチルフェニル基
など)、アルコキシカルボニル基(例えば、メトキシカ
ルボニル基、エトキシカルボニル基、ベンジルオキシカ
ルボニル基など)、アリールオキシカルボニル基(例え
ばフェノキシカルボニル基など)、アシル基(例えば、
アセチル基、プロピオニル基、ベンゾイル基、p−トル
エンスルホニル基など)が挙げられるが、これに限定さ
れるものではない。Embedded image In the compound represented by the formula, Z represents NR 1 , an oxygen atom or a sulfur atom, and R 1 is, for example, a hydrogen atom, an unsubstituted alkyl group (for example, a methyl group, an ethyl group, a propyl group, an isopropyl group, an octyl group) , A decyl group, a cyclohexyl group, etc.), an alkyl group having a substituent (for example, a carboxyl group, a halogen atom (eg, a fluorine atom, a chlorine atom, etc.), a hydroxyl group, an alkoxycarbonyl group (eg, methoxycarbonyl) Group, ethoxycarbonyl group, benzyloxycarbonyl group, etc.), aryloxycarbonyl group (eg, phenoxycarbonyl group, etc.), alkoxy group (eg, methoxy group, ethoxy group, benzyloxy group, phenethyloxy group, etc.), monocyclic group Aryloxy group (for example, phenoxy group, p-to A carbamoyl group (eg, carbamoyl group, N, N-dimethylcarbamoyl group, morpholinocarbonyl group, piperidinocarbonyl group, etc.), an acyloxy group (eg, acetyloxy group, propionyloxy group, capryloxy group, etc.) ), A sulfamoyl group (eg, a sulfamoyl group, an N, N-dimethylsulfamoyl group, a morpholinosulfamoyl group, etc.), an acylamino group (eg, an acetylamino group, a propionylamino group, a benzoylamino group, a mesylamino group, etc.), Examples thereof include a sulfonamide group (for example, an ethylsulfonamide group, a p-toluenesulfonamide group, etc.), an alkenyl group (for example, an allyl group, a 3-butenyl group, and the like), and an aralkyl group (for example, a benzyl group, -Chlorobenzyl group , 4
-Methylbenzyl group, 1-naphthylmethyl group, etc.), aryl group (eg, phenyl group, 4-methylphenyl group, etc.), alkoxycarbonyl group (eg, methoxycarbonyl group, ethoxycarbonyl group, benzyloxycarbonyl group, etc.), Aryloxycarbonyl group (for example, phenoxycarbonyl group etc.), acyl group (for example,
Acetyl, propionyl, benzoyl, p-toluenesulfonyl, etc.), but are not limited thereto.
【0014】R2 は例えば、水素原子、ハロゲン原子
(例えば、フッ素原子、塩素原子など)、置換もしくは
未置換のアルキル基(R1 として示した置換基と同じも
のを挙げることが出来る)、アルケニル基(例えば、ア
リル基、3−ブテニル基など)、アラルキル基(例え
ば、ベンジル基、4−クロロベンジル基、4−メチルベ
ンジル基、1−ナフチルメチル基など)、アリール基
(例えば、フェニル基、4−メチルフェニル基など)、
アルコキシ基(例えば、メトキシ基、エトキシ基、ベン
ジルオキシ基、フェネチルオキシ基など)、アリールオ
キシ基(例えば、フェノキシ基など)、アルコキシカル
ボニル基(例えば、メトキシカルボニル基、エトキシカ
ルボニル基、ベンジルオキシカルボニル基など)、アリ
ールオキシカルボニル基(例えばフェノキシカルボニル
基など)、アシルオキシ基(例えば、アセチルオキシ
基、プロピオニルオキシ基、カプリルオキシ基など)、
アシル基(例えば、アセチル基、プロピオニル基、ベン
ゾイル基、p−トルエンスルホニル基など)、ヒドロキ
シル基又はカルボキシル基が挙げられるが、これに限定
されるものではない。R 2 is, for example, a hydrogen atom, a halogen atom (eg, a fluorine atom, a chlorine atom, etc.), a substituted or unsubstituted alkyl group (the same substituents as R 1 ), alkenyl Groups (eg, allyl group, 3-butenyl group, etc.), aralkyl groups (eg, benzyl group, 4-chlorobenzyl group, 4-methylbenzyl group, 1-naphthylmethyl group, etc.), aryl groups (eg, phenyl group, 4-methylphenyl group),
Alkoxy group (eg, methoxy group, ethoxy group, benzyloxy group, phenethyloxy group, etc.), aryloxy group (eg, phenoxy group, etc.), alkoxycarbonyl group (eg, methoxycarbonyl group, ethoxycarbonyl group, benzyloxycarbonyl group) ), An aryloxycarbonyl group (for example, a phenoxycarbonyl group, etc.), an acyloxy group (for example, an acetyloxy group, a propionyloxy group, a capryloxy group, etc.),
Examples include, but are not limited to, acyl groups (eg, acetyl, propionyl, benzoyl, p-toluenesulfonyl, etc.), hydroxyl, and carboxyl.
【0015】R3 は水素原子、置換もしくは未置換のア
ルキル基(R1 として示した置換基と同じものを挙げる
ことが出来る)、アルケニル基(例えば、アリル基、3
−ブテニル基など)、アラルキル基(例えば、ベンジル
基、4−クロロベンジル基、4−メチルベンジル基、1
−ナフチルメチル基など)、アシル基(例えば、アセチ
ル基、プロピオニル基、ベンゾイル基、p−トルエンス
ルホニル基など)が挙げられるが、これに限定されるも
のではない。R 3 is a hydrogen atom, a substituted or unsubstituted alkyl group (the same substituents as R 1 can be mentioned), an alkenyl group (for example, allyl group, 3
-Butenyl group), an aralkyl group (for example, benzyl group, 4-chlorobenzyl group, 4-methylbenzyl group, 1
-Naphthylmethyl group) and an acyl group (e.g., acetyl group, propionyl group, benzoyl group, p-toluenesulfonyl group, etc.), but are not limited thereto.
【0016】本発明の出発物質である前記一般式(I)
で表わされる3−イミノピロリジン類は、例えば「ジャ
ーナル・オブ・メディシナル・ケミストリー(Journal o
f Medicinal Chemistry)」24巻(10号),1244
頁(1981)に記載の方法、又はこの方法に準じて容
易に合成することが出来る。The starting material of the present invention has the above general formula (I)
3-iminopyrrolidines represented by, for example, "Journal of Medicinal Chemistry (Journal o
f Medicinal Chemistry) ”Vol. 24 (No. 10), 1244
The compound can be easily synthesized according to the method described on page (1981) or according to this method.
【0017】前記一般式(I)で表わされる3−イミノ
ピロリジン類を還元して3−アミノピロリジン類を得る
のに、触媒として金属ボライドを用いる。金属として
は、ニッケル、コバルトを単独又は組み合わせて使用す
る。金属ボライドは、例えば「インダストリアル・アン
ド・エンジニアリング・ケミストリー(Industr
ial and Engineering Chemi
stry)」44巻 1006頁(1952)に示され
ている方法や、「ジャーナル・オブ・オーガニック・ケ
ミストリー(Journal of Organic
Chemistry)35巻(6号),1900頁(1
970)に示されている方法で容易に調製することが出
来る。金属ボライドの使用量は、前記一般式(I)で表
わされる3−イミノピロリジン誘導体に対して0.01
〜50モルパーセントの範囲にあるが1〜20モルパー
セントの範囲が特に好ましい。For reducing 3-iminopyrrolidine represented by the above general formula (I) to obtain 3-aminopyrrolidine, a metal boride is used as a catalyst. As the metal, nickel or cobalt is used alone or in combination. Metal boride is described, for example, in "Industrial and Engineering Chemistry (Industr).
ial and Engineering Chemi
story) ", 44, 1006 (1952), and" Journal of Organic Chemistry ".
Chemistry) 35 (6), 1900 p.
970) can be easily prepared. The amount of the metal boride used is 0.01 to the 3-iminopyrrolidine derivative represented by the general formula (I).
It is in the range of 5050 mole percent, with the range of 1-20 mole percent being particularly preferred.
【0018】還元剤としては、ソジウムボロハイドライ
ド、リチウムボロハイドライド、ポタシウムボロハイド
ライド等が例示でき、単独又は組み合わせて使用する。
還元剤の使用量は当量以上なら特に制約はないが、3当
量以下が好ましい。Examples of the reducing agent include sodium borohydride, lithium borohydride, potassium borohydride and the like, and these are used alone or in combination.
The amount of the reducing agent is not particularly limited as long as it is equal to or more than an equivalent, but is preferably equal to or less than 3 equivalents.
【0019】反応溶媒としては、水、メタノール、エタ
ノール、イソプロパノール、ジエチルエーテル、テトラ
ヒドロフラン、ジオキサン、モノグライム又はこれらの
混合溶媒を用いることが出来る。溶媒の使用量は、使用
する3−イミノピロリジン類の溶媒に対する溶解度によ
り異なり、特に制約はないが、約2〜20倍容量を例示
することができる。As a reaction solvent, water, methanol, ethanol, isopropanol, diethyl ether, tetrahydrofuran, dioxane, monoglyme or a mixed solvent thereof can be used. The amount of the solvent used depends on the solubility of the 3-iminopyrrolidine used in the solvent, and is not particularly limited, but may be about 2 to 20 times the volume.
【0020】反応は、常圧又は加圧下に行われ、−80
°〜120°Cで進行するが、−30°〜80°Cで行
うことが好ましい。反応終了後、反応液を例えば室温近
くまで冷却し、析出した無機物を除去後、濃縮し粗製の
目的物を得ることができる。又、例えば、酢酸エチル、
トルエン、クロロホルム、ヘキサン、エーテル等の有機
溶媒で反応物を抽出後、濃縮し粗製の目的物を得ること
ができる。次に必要に応じて、蒸留又は再結晶する事に
より、高品質な前記一般式(II)で表わされる3−ア
ミノピロリジン類を得ることが出来る。The reaction is carried out at normal pressure or under pressure,
Although the process proceeds at a temperature of from about ° C to about 120 ° C, it is preferably performed at a temperature of from about -30 ° to about 80 ° C. After the completion of the reaction, the reaction solution is cooled to, for example, near room temperature, and after removing precipitated inorganic substances, the resultant is concentrated to obtain a crude target substance. Also, for example, ethyl acetate,
The reaction product is extracted with an organic solvent such as toluene, chloroform, hexane, or ether, and then concentrated to obtain a crude target product. Next, if necessary, high-quality 3-aminopyrrolidines represented by the general formula (II) can be obtained by distillation or recrystallization.
【0021】[0021]
【実施例】以下に参考例及び実施例により、本発明を更
に詳しく説明するが、これに限定されることはない。 (参考例−1)塩酸ヒドロキシルアミン25.7gを水
50ml、メタノール80mlに溶解する。1−ベンジ
ル−2−メチル−3−ピロリジノン35g(0.185
モル)をメタノール20mlに希釈し、約30℃で滴下
する。炭酸カリウム25.8gを加え20〜30℃で3
0分反応させてから、水300mlを徐々に滴下する。
晶析した結晶を濾別、水洗して1−ベンジル−2−メチ
ル−3−ヒドロキシイミノピロリジン35.0gを得
た。(収率92.6%)mp.97〜99℃ NMRスペクトル(CDCl3 )δ:1.3(3H,
d),2.2(1H,q),2.6(2H,t),3.
0(2H,t),3.7(2H,d),7.3(5H,
m),8.7(1H,s) (参考例−2)1−ベンジル−2−メチル−3−ヒドロ
キシイミノピロリジン20.4g(0.10モル)、ラ
ネーニッケル5g、メタノール100mlを200ml
オートクレーブに仕込み、水素圧を20kg/cm2 に
して、40〜50℃で1時間反応する。触媒を濾別後、
濃縮、蒸留して、1−ベンジル−2−メチル−3−アミ
ノピロリジン9.8gを得た。(収率52.0%) bp.120℃/0.4mmHg NMRスペクトル(CDCl3 )δ:1.1(3H,
d),1.4(2H,s),1.5(1H,m),2.
0(2H,m),2.3(1H,m),2.8(1H,
m),3.1(1H,d),3.2(1H,m),3.
9(1H,d),7.3(5H,s) G.C.(OV−22,3%,2m)cis 異性体 50% trans異性体 50% (実施例−1)1−ベンジル−2−メチル−3−ヒドロ
キシイミノピロリジン6.3g(0.031モル)、塩
化ニッケル(II)・6水和物0.37gをエタノール
23mlに溶解し、10℃まで冷却する。ソジウムボロ
ハイドライド2.0gを水7mlに溶解したものを、1
0〜20℃で滴下し、室温で1時間反応する。析出した
無機物を濾別後、濃縮、蒸留して、1−ベンジル−2−
メチル−3−アミノピロリジン5.2gを得た。(収率
88.2%) bp.120℃/0.4mmHg NMRスペクトル(CDCl3 )δ:1.1(3H,
d),1.4(2H,s),1.5(1H,m),2.
0(2H,m),2.3(1H,m),2.8(1H,
m),3.1(1H,d),3.2(1H,m),3.
9(1H,d),7.3(5H,s) G.C.(OV−22,3%,2m)cis 異性体 88% trans異性体 12% (実施例−2)1−ベンジル−2−メチル−3−ヒドロ
キシイミノピロリジン6.3g(0.031モル)、塩
化ニッケル(II)・6水和物0.37gをメタノール
23mlに溶解し、−20℃まで冷却する。ソジウムボ
ロハイドライド2.0gを水7mlに溶解したものを、
−10℃以下で滴下し、そのまま1時間反応する。反応
液に5N−塩酸を加えてpH6とし触媒のニッケルボラ
イドを溶解してから、水20mlを加え、クロロホルム
30mlで抽出した。濃縮後、蒸留して1−ベンジル−
2−メチル−3−アミノピロリジン5.0gを得た。
(収率84.8%)bp.120℃/0.4mmHg G.C.(OV−22,3%,2m)cis 異性体 94% trans異性体 6% (実施例−3)ソジウムボロハイドライド10%水溶液
27mlを塩化ニッケル(II)5%水溶液121ml
に攪拌しながら加える。析出した黒色のニッケルボライ
ドを空気に触れることなく濾別し、エタノール溶液中に
保存する。The present invention will be described in more detail with reference to the following Reference Examples and Examples, which should not be construed as limiting the invention. Reference Example 1 25.7 g of hydroxylamine hydrochloride was dissolved in 50 ml of water and 80 ml of methanol. 35 g of 1-benzyl-2-methyl-3-pyrrolidinone (0.185
Mol) in 20 ml of methanol and added dropwise at about 30 ° C. Add 25.8 g of potassium carbonate, and add 3 at 20-30 ° C.
After reacting for 0 minutes, 300 ml of water is gradually added dropwise.
The crystallized crystals were separated by filtration and washed with water to obtain 15.0 g of 1-benzyl-2-methyl-3-hydroxyiminopyrrolidine. (Yield 92.6%) mp. 97-99 ° C. NMR spectrum (CDCl 3 ) δ: 1.3 (3H,
d), 2.2 (1H, q), 2.6 (2H, t), 3.
0 (2H, t), 3.7 (2H, d), 7.3 (5H,
m), 8.7 (1H, s) (Reference Example-2) 20.4 g (0.10 mol) of 1-benzyl-2-methyl-3-hydroxyiminopyrrolidine, 5 g of Raney nickel, and 200 ml of methanol 100 ml
The mixture is charged into an autoclave, and the reaction is carried out at 40 to 50 ° C. for 1 hour at a hydrogen pressure of 20 kg / cm 2 . After filtering off the catalyst,
After concentration and distillation, 9.8 g of 1-benzyl-2-methyl-3-aminopyrrolidine was obtained. (Yield 52.0%) bp. 120 ° C./0.4 mmHg NMR spectrum (CDCl 3 ) δ: 1.1 (3H,
d), 1.4 (2H, s), 1.5 (1H, m), 2.
0 (2H, m), 2.3 (1H, m), 2.8 (1H,
m), 3.1 (1H, d), 3.2 (1H, m), 3.
9 (1H, d), 7.3 (5H, s) C. (OV-22, 3%, 2m) cis isomer 50% trans isomer 50% (Example-1) 6.3 g (0.031 mol) of 1-benzyl-2-methyl-3-hydroxyiminopyrrolidine, chloride 0.37 g of nickel (II) hexahydrate is dissolved in 23 ml of ethanol and cooled to 10 ° C. A solution of 2.0 g of sodium borohydride in 7 ml of water was added to 1
The solution is added dropwise at 0 to 20 ° C., and reacted at room temperature for 1 hour. The precipitated inorganic substance was separated by filtration, concentrated and distilled to give 1-benzyl-2-
5.2 g of methyl-3-aminopyrrolidine were obtained. (Yield 88.2%) bp. 120 ° C./0.4 mmHg NMR spectrum (CDCl 3 ) δ: 1.1 (3H,
d), 1.4 (2H, s), 1.5 (1H, m), 2.
0 (2H, m), 2.3 (1H, m), 2.8 (1H,
m), 3.1 (1H, d), 3.2 (1H, m), 3.
9 (1H, d), 7.3 (5H, s) C. (OV-22, 3%, 2m) cis isomer 88% trans isomer 12% (Example-2) 6.3 g (0.031 mol) of 1-benzyl-2-methyl-3-hydroxyiminopyrrolidine, chloride 0.37 g of nickel (II) hexahydrate is dissolved in 23 ml of methanol and cooled to -20 ° C. Sodium borohydride 2.0g dissolved in water 7ml,
The solution is added dropwise at -10 ° C or lower, and the reaction is performed for 1 hour. The reaction solution was adjusted to pH 6 by adding 5N-hydrochloric acid to dissolve the nickel boride as a catalyst, and then added with 20 ml of water and extracted with 30 ml of chloroform. After concentration, distillation to give 1-benzyl-
5.0 g of 2-methyl-3-aminopyrrolidine was obtained.
(Yield 84.8%) bp. 120 ° C./0.4 mmHg C. (OV-22, 3%, 2m) cis isomer 94% trans isomer 6% (Example-3) 27 ml of a 10% aqueous solution of sodium borohydride and 121 ml of a 5% aqueous solution of nickel (II) chloride
While stirring. The precipitated black nickel boride is filtered off without contact with air and stored in an ethanol solution.
【0022】1−ベンジル−2−メチル−3−ヒドロキ
シイミノピロリジン6.3g(0.031モル)、上記
の方法で調整したニッケルボライド0.63g、エタノ
ール23mlを仕込む。ソジウムボロハイドライド1.
5gを水5.3mlに溶解したものを、10〜20℃で
滴下し、室温で1時間反応する。析出した無機物を濾別
後、濃縮、蒸留して、1−ベンジル−2−メチル−3−
アミノピロリジン5.1gを得た。(収率86.5%) bp.120℃/0.4mmHg G.C.(OV−22,3%,2m)cis 異性体 87% trans異性体 13% (実施例−4)1−ベンジル−2−メチル−3−ヒドロ
キシイミノピロリジン6.3g(0.031モル)、塩
化コバルト(II)・6水和物0.50gをエタノール
23mlに溶解し、10℃まで冷却する。ソジウムボロ
ハイドライド2.0gを水7mlに溶解したものを、1
0〜20℃で滴下し、室温で1時間反応する。析出した
無機物を濾別後、濃縮、蒸留して、1−ベンジル−2−
メチル−3−アミノピロリジン4.8gを得た。(収率
81.4%) bp.120℃/0.4mmHg G.C.(OV−22,3%,2m)cis 異性体 86% trans異性体 14% (実施例−5)1−ベンジル−2−メチル−3−メトキ
シイミノピロリジン6.7g(0.031モル)、塩化
ニッケル(II)・6水和物0.37gをエタノール2
3mlに溶解し、10℃に冷却する。ソジウムボロハイ
ドライド2.0gを水7mlに溶解したものを、10〜
20℃で滴下した後、室温で1時間反応する。析出した
無機物を濾別後、濃縮、蒸留して、1−ベンジル−2−
メチル−3−アミノピロリジン5.1gを得た。(収率
86.5%) bp.120℃/0.4mmHg G.C.(OV−22,3%,2m)cis 異性体 87% trans異性体 13% (実施例−6)1−ベンジル−2−エチル−3−ヒドロ
キシイミノピロリジン6.7g(0.031モル)、塩
化ニッケル(II)・6水和物0.37gをエタノール
23mlに溶解し、10℃に冷却する。ソジウムボロハ
イドライド2.0gを水7mlに溶解したものを、10
〜16℃で滴下した後、室温で1時間反応する。析出し
た無機物を濾別後、濃縮、蒸留して、1−ベンジル−2
−エチル−3−アミノピロリジン5.8gを得た。(収
率91.6%) bp.130℃/0.4mmHg G.C.(OV−22,3%,2m)cis 異性体 89% trans異性体 11% (実施例−7)1−n−プロピル−2−メチル−3−ヒ
ドロキシイミノピロリジン0.78g(0.005モ
ル)、塩化ニッケル(II)・6水和物0.089gを
エタノール3mlに溶解し、10℃に冷却する。ソジウ
ムボロハイドライド0.38gを水1.5mlに溶解し
たものを、10〜16℃で滴下した後、40℃で1時間
反応する。析出した無機物を濾別後、濃縮、蒸留して、
1−n−プロピル−2−メチル−3−アミノピロリジン
0.46gを得た。(収率64.7%) bp.90℃/0.2mmHg G.C.(OV−22,3%,2m)cis 異性体 85% trans異性体 15% (実施例−8)1−ベンジル−5−メチル−3−ヒドロ
キシイミノピロリジン2.1g(0.01モル)、塩化
ニッケル(II)・6水和物0.15gをエタノール8
mlに溶解する。ソジウムボロハイドライド0.8gを
水3mlに溶解したものを、13〜20℃で滴下し1時
間反応する。析出した無機物を濾別後、濃縮、蒸留し
て、1−ベンジル−5−メチル−3−アミノピロリジン
1.6gを得た。(収率84.1%) bp.115℃/0.4mmHg NMRスペクトル(CDCl3 )δ:1.19(3H,
d),1.40(1H,s)1.5〜2.7(6H.
m),3.1(1H,d),4.0(1H,d),7.
3(5H,s) G.C.(OV−22,3%,2m)cis 異性体 78% trans異性体 22% (実施例−9)3−ヒドロキシイミノ−2−メチルテト
ラヒドロフラン0.58g(0.005モル)、塩化ニ
ッケル(II)・6水和物0.09gをエタノール1.
5mlに溶解する。ソジウムボロハイドライド0.38
gを水1.5mlに溶解したものを10〜14℃で滴下
した後、40℃で1時間反応する。析出した無機物を濾
別後、濃縮、蒸留して3−アミノ−2−メチルテトラヒ
ドロフラン0.21gを得た。(収率41.2%) b.p.50℃/0.5mmHg NMRスペクトル(CDCl3 )δ:1.2(3H,
d),1.5(2H,br.s),1.7(2H,t
d),2.2(2H,dt),3.3〜3.6(1H,
m),3.7〜4.0(2H,m) G.C.(OV−22,3%,2m)cis 異性体 79% trans異性体 21% (実施例−10〜実施例−17)上記実施例−1〜実施
例−9と同様にして以下の化合物を合成した。6.3 g (0.031 mol) of 1-benzyl-2-methyl-3-hydroxyiminopyrrolidine, 0.63 g of nickel boride prepared by the above method and 23 ml of ethanol are charged. Sodium borohydride
What melt | dissolved 5 g in 5.3 ml of water was dripped at 10-20 degreeC, and it reacted at room temperature for 1 hour. The precipitated inorganic substance was separated by filtration, concentrated and distilled to give 1-benzyl-2-methyl-3-.
5.1 g of aminopyrrolidine were obtained. (Yield 86.5%) bp. 120 ° C./0.4 mmHg C. (OV-22, 3%, 2m) cis isomer 87% trans isomer 13% (Example-4) 6.3 g (0.031 mol) of 1-benzyl-2-methyl-3-hydroxyiminopyrrolidine, chloride 0.50 g of cobalt (II) hexahydrate is dissolved in 23 ml of ethanol and cooled to 10 ° C. A solution of 2.0 g of sodium borohydride in 7 ml of water was added to 1
The solution is added dropwise at 0 to 20 ° C., and reacted at room temperature for 1 hour. The precipitated inorganic substance was separated by filtration, concentrated and distilled to give 1-benzyl-2-
4.8 g of methyl-3-aminopyrrolidine were obtained. (Yield 81.4%) bp. 120 ° C./0.4 mmHg C. (OV-22, 3%, 2m) cis isomer 86% trans isomer 14% (Example-5) 6.7 g (0.031 mol) of 1-benzyl-2-methyl-3-methoxyiminopyrrolidine, chloride 0.37 g of nickel (II) hexahydrate in ethanol 2
Dissolve in 3 ml and cool to 10 ° C. A solution of 2.0 g of sodium borohydride in 7 ml of water
After dropwise addition at 20 ° C., the reaction is carried out at room temperature for 1 hour. The precipitated inorganic substance was separated by filtration, concentrated and distilled to give 1-benzyl-2-
5.1 g of methyl-3-aminopyrrolidine were obtained. (Yield 86.5%) bp. 120 ° C./0.4 mmHg C. (OV-22, 3%, 2m) cis isomer 87% trans isomer 13% (Example-6) 6.7 g (0.031 mol) of 1-benzyl-2-ethyl-3-hydroxyiminopyrrolidine, chloride 0.37 g of nickel (II) hexahydrate is dissolved in 23 ml of ethanol and cooled to 10 ° C. A solution of 2.0 g of sodium borohydride in 7 ml of water was added to 10 g
After dropwise addition at 16 ° C., the reaction is carried out at room temperature for 1 hour. The precipitated inorganic substance was separated by filtration, concentrated and distilled to give 1-benzyl-2.
5.8 g of -ethyl-3-aminopyrrolidine were obtained. (Yield 91.6%) bp. 130 ° C./0.4 mmHg C. (OV-22, 3%, 2m) cis isomer 89% trans isomer 11% (Example-7) 1-n-propyl-2-methyl-3-hydroxyiminopyrrolidine 0.78 g (0.005 mol) Then, 0.089 g of nickel (II) chloride hexahydrate was dissolved in 3 ml of ethanol and cooled to 10 ° C. A solution obtained by dissolving 0.38 g of sodium borohydride in 1.5 ml of water is added dropwise at 10 to 16 ° C, and then reacted at 40 ° C for 1 hour. After filtering off the precipitated inorganic substance, concentration and distillation,
0.46 g of 1-n-propyl-2-methyl-3-aminopyrrolidine was obtained. (Yield 64.7%) bp. 90 ° C./0.2 mmHg C. (OV-22, 3%, 2m) cis isomer 85% trans isomer 15% (Example-8) 2.1 g (0.01 mol) of 1-benzyl-5-methyl-3-hydroxyiminopyrrolidine, chloride 0.15 g of nickel (II) hexahydrate was added to ethanol 8
Dissolve in ml. A solution obtained by dissolving 0.8 g of sodium borohydride in 3 ml of water is added dropwise at 13 to 20 ° C. and reacted for 1 hour. The precipitated inorganic substance was separated by filtration, concentrated and distilled to obtain 1-benzyl-5-methyl-3-aminopyrrolidine (1.6 g). (Yield 84.1%) bp. 115 ° C./0.4 mmHg NMR spectrum (CDCl 3 ) δ: 1.19 (3H,
d), 1.40 (1H, s) 1.5 to 2.7 (6H.
m), 3.1 (1H, d), 4.0 (1H, d), 7.
3 (5H, s) C. (OV-22, 3%, 2m) cis isomer 78% trans isomer 22% (Example-9) 0.58 g (0.005 mol) of 3-hydroxyimino-2-methyltetrahydrofuran, nickel (II) chloride 0.09 g of hexahydrate was added to ethanol 1.
Dissolve in 5 ml. Sodium borohydride 0.38
g in 1.5 ml of water was added dropwise at 10 to 14 ° C, and the reaction was carried out at 40 ° C for 1 hour. The precipitated inorganic substance was separated by filtration, concentrated and distilled to obtain 0.21 g of 3-amino-2-methyltetrahydrofuran. (Yield 41.2%) b. p. 50 ° C./0.5 mmHg NMR spectrum (CDCl 3 ) δ: 1.2 (3H,
d), 1.5 (2H, br.s), 1.7 (2H, t)
d), 2.2 (2H, dt), 3.3 to 3.6 (1H,
m), 3.7-4.0 (2H, m). C. (OV-22, 3%, 2m) cis isomer 79% trans isomer 21% (Examples -10 to -17) The following compounds were synthesized in the same manner as in the above Examples -1 to -9. did.
【0023】[0023]
【表1】 [Table 1]
【0024】[0024]
【発明の効果】下記一般式(I)The following general formula (I)
【0025】[0025]
【化7】 〔式中、ZはN−R1 、酸素原子又は硫黄原子を表わ
し、R1 は水素原子、置換もしくは未置換のアルキル
基、アルケニル基、アラルキル基、アリール基、アルコ
キシカルボニル基、アリールオキシカルボニル基、又は
アシル基を表し、R2 は水素原子、ハロゲン原子、置換
もしくは未置換のアルキル基、アルケニル基、アラルキ
ル基、アリール基、ヒドロキシル基、アルコキシ基、ア
リールオキシ基、アシルオキシ基、カルボキシル基、ア
ルコキシカルボニル基、アリールオキシカルボニル基、
又はアシル基を表し、R3は水素原子、置換もしくは未
置換のアルキル基、アルケニル基、アラルキル基、アシ
ル基を表わす。〕で表わされる3−イミノピロリジン類
を、M2 B〔Mはニッケル又はコバルトを表わす。〕で
表わされる金属ボライドの存在下で常圧下温和な条件で
還元して、上記3−イミノピロリジン類に対応する3−
アミノピロリジン類において、3位のアミノ基とそれぞ
れ2位、4位又は5位の置換基がcis配置である異性
体を高選択的に得ることができた。Embedded image [In the formula, Z represents NR 1 , an oxygen atom or a sulfur atom, and R 1 represents a hydrogen atom, a substituted or unsubstituted alkyl group, an alkenyl group, an aralkyl group, an aryl group, an alkoxycarbonyl group, an aryloxycarbonyl group. Or an acyl group, and R 2 represents a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group, an alkenyl group, an aralkyl group, an aryl group, a hydroxyl group, an alkoxy group, an aryloxy group, an acyloxy group, a carboxyl group, an alkoxy group. Carbonyl group, aryloxycarbonyl group,
R 3 represents a hydrogen atom, a substituted or unsubstituted alkyl group, an alkenyl group, an aralkyl group, or an acyl group. Represented by 3-iminopyrrolidine acids in], M 2 B [M represents a nickel or cobalt. Under the normal pressure and mild conditions in the presence of the metal boride represented by the formula (3) corresponding to the 3-iminopyrrolidines
In the aminopyrrolidines, isomers in which the amino group at the 3-position and the substituent at the 2-, 4-, or 5-position, respectively, have a cis configuration could be obtained with high selectivity.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI C07D 333/38 C07D 333/38 (72)発明者 佐藤 裕司 神奈川県平塚市東八幡5丁目2番3号 三協化学株式会社 合成化学研究所内 (56)参考文献 特開 昭55−22699(JP,A) 特開 昭63−277655(JP,A) (58)調査した分野(Int.Cl.7,DB名) C07D 207/14 C07D 207/16 C07D 307/22 C07D 307/24 C07D 333/36 C07D 333/38 CA(STN) CAOLD(STN) REGISTRY(STN)──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI C07D 333/38 C07D 333/38 (72) Inventor Yuji 5- 2-3 Higashi-Hachiman, Hiratsuka-shi, Kanagawa Sankyo Chemical Co., Ltd. (56) References JP-A-55-22699 (JP, A) JP-A-63-277655 (JP, A) (58) Fields investigated (Int. Cl. 7 , DB name) C07D 207/14 C07D 207/16 C07D 307/22 C07D 307/24 C07D 333/36 C07D 333/38 CA (STN) CAOLD (STN) REGISTRY (STN)
Claims (2)
し、R1 は水素原子、置換もしくは未置換のアルキル
基、アルケニル基、アラルキル基、アリール基、アルコ
キシカルボニル基、アリールオキシカルボニル基、又は
アシル基を表し、R2 は水素原子、ハロゲン原子、置換
もしくは未置換のアルキル基、アルケニル基、アラルキ
ル基、アリール基、ヒドロキシル基、アルコキシ基、ア
リールオキシ基、アシルオキシ基、カルボキシル基、ア
ルコキシカルボニル基、アリールオキシカルボニル基、
又はアシル基を表し、R3は水素原子、置換もしくは未
置換のアルキル基、アルケニル基、アラルキル基、アシ
ル基を表わす。〕で表わされる3−イミノピロリジン類
を、 一般式(III) M2 B 〔式中、Mはニッケル又はコバルトを表わす。〕で表わ
される金属ボライドの存在下で還元することを特徴とす
る、 一般式(II) 【化2】 〔式中、Z、R2 は前記一般式(I)と同じ意味であ
る。〕で表わされる3−アミノピロリジン類の製造方
法。1. A compound represented by the following general formula (I) [In the formula, Z represents NR 1 , an oxygen atom or a sulfur atom, and R 1 represents a hydrogen atom, a substituted or unsubstituted alkyl group, an alkenyl group, an aralkyl group, an aryl group, an alkoxycarbonyl group, an aryloxycarbonyl group. Or an acyl group, and R 2 represents a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group, an alkenyl group, an aralkyl group, an aryl group, a hydroxyl group, an alkoxy group, an aryloxy group, an acyloxy group, a carboxyl group, an alkoxy group. Carbonyl group, aryloxycarbonyl group,
R 3 represents a hydrogen atom, a substituted or unsubstituted alkyl group, an alkenyl group, an aralkyl group, or an acyl group. A 3-iminopyrrolidine represented by the general formula (III): M 2 B wherein M represents nickel or cobalt. Wherein the reduction is carried out in the presence of a metal boride represented by the general formula (II): [Wherein, Z and R 2 have the same meanings as in the general formula (I). ] The method for producing 3-aminopyrrolidines represented by the formula:
る。〕で表わされる3−アミノピロリジン類において、
3位のアミノ基とそれぞれ2位、4位又は5位の置換基
がcis配置である異性体を高選択的に得ることを特徴
とする請求項1に記載の製造方法。2. The following general formula (II): [Wherein, Z and R 2 have the same meanings as in the general formula (I). 3-aminopyrrolidines represented by the formula:
The method according to claim 1, wherein an isomer having a cis configuration in which the amino group at the 3-position and the substituent at the 2-, 4- or 5-position, respectively, are obtained in a highly selective manner.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP03160877A JP3086837B2 (en) | 1991-06-06 | 1991-06-06 | Method for producing 3-aminopyrrolidines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP03160877A JP3086837B2 (en) | 1991-06-06 | 1991-06-06 | Method for producing 3-aminopyrrolidines |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04360866A JPH04360866A (en) | 1992-12-14 |
JP3086837B2 true JP3086837B2 (en) | 2000-09-11 |
Family
ID=15724308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP03160877A Expired - Fee Related JP3086837B2 (en) | 1991-06-06 | 1991-06-06 | Method for producing 3-aminopyrrolidines |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3086837B2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5252747A (en) * | 1992-09-11 | 1993-10-12 | Abbott Laboratories | Chiral quinolone intermediates |
CN1051765C (en) * | 1996-06-25 | 2000-04-26 | 厦门大学 | Stereoselective synthesizing process for enantiomorph pure 3-amino-1,2-twice substituted pyrrolidine |
CN1051764C (en) * | 1996-06-25 | 2000-04-26 | 厦门大学 | Stereoselective synthesizing process for enantiomorph pure 3-amino-1,2-twice substituted pyrrolidine |
ES2615738T3 (en) * | 2011-05-13 | 2017-06-08 | Array Biopharma, Inc. | Compounds of pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine as trkA kinase inhibitors |
-
1991
- 1991-06-06 JP JP03160877A patent/JP3086837B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH04360866A (en) | 1992-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07215921A (en) | Method for producing pest control agent and intermediate | |
JP3086837B2 (en) | Method for producing 3-aminopyrrolidines | |
JP5548129B2 (en) | Asymmetric organic catalyst | |
DE69811893T2 (en) | METHOD FOR PRODUCING AZETIDINE-2-CARBONIC ACID AND INTERMEDIATE PRODUCTS THEREOF | |
JP3167705B2 (en) | Method for producing 3- (N-benzyl-N-alkoxycarbonylalkylamino) propionic acid ester | |
AU2004236009A1 (en) | Method for the synthesis of 4-hydroxyisoleucine and the derivatives thereof | |
JP4984676B2 (en) | Preparation of aniline having benzyloxy group | |
JPH09316053A (en) | Production of sulfonamide derivative and intermediate thereof | |
US6320069B1 (en) | Production of optically active ketone | |
JP3140698B2 (en) | Production method and purification method of 4-hydroxy-2-pyrrolidinone | |
JP5054686B2 (en) | Method for producing ester or alcohol | |
JP2002371060A (en) | Method for producing optically active aminopiperidine derivative | |
JP2815969B2 (en) | 3-Aminophenol derivative and method for producing the same | |
JPH072742A (en) | New production method of 4-amino-3-methyl-n-ethyl-n-(beta-hydroxyethyl)aniline sulfuric acid salt | |
JPWO2005000810A1 (en) | Method for producing nitrogen-containing heterocyclic compound | |
KR100288404B1 (en) | 2-Benzothiazolyl 4-amino-5-chloro-2-methoxythiobenzoate And Process For Preparing Cisapride Employing The Same | |
JP2003137835A (en) | Method for producing (r)-3-hydroxy-3-(2-phenyl)hexanoic acid | |
JP2608714B2 (en) | Method for producing 1,2,3-triazole and its derivative | |
JP2958835B2 (en) | Method for producing 4- (1-carboxyalkyl) azetidin-2-one derivative | |
CN115368283A (en) | Preparation method of cis-3-fluoro-4-hydroxypyrrolidine with chiral structure or achiral structure and derivatives thereof | |
JP4314603B2 (en) | Process for producing optically active 3-alkoxycarbonylaminopyrrolidine derivative | |
FR2555582A1 (en) | PROCESS FOR THE PREPARATION OF 4- (2-PHENOXYETHYL) -1,2,4-TRIAZOLONE | |
JPH1045721A (en) | Production of 1-substituted-4,5-diphenyl-2-imidazolidinone and intermediate for the same | |
CH632768A5 (en) | PROCESS FOR OBTAINING N, N'-BIS- (3-OXAZOLIDINYL-2-ONE) -P-SUBSTITUTED PHOSPHORAMIDES AND N, N'-BIS- (3-OXAZOLIDINYL-2-ONE) -P-SUBSTITUTED PHOSPHORAMIDES . | |
BE553109A (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080714 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080714 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090714 Year of fee payment: 9 |
|
LAPS | Cancellation because of no payment of annual fees |